Influence of continuous erythropoietin receptor activator on markers of cardiovascular risk in chronic kidney disease patients

Int J Cardiol. 2013 Sep 10;167(6):3070-2. doi: 10.1016/j.ijcard.2012.11.073. Epub 2012 Dec 4.
No abstract available

Keywords: Chronic kidney disease; Continuous erythropoietin receptor activator; Homocysteine; Inflammatory markers; Renal anemia.

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / drug therapy*
  • Erythropoietin / administration & dosage*
  • Female
  • Humans
  • Male
  • Pilot Projects
  • Polyethylene Glycols / administration & dosage*
  • Renal Insufficiency, Chronic / blood*
  • Renal Insufficiency, Chronic / drug therapy*
  • Risk Factors

Substances

  • Biomarkers
  • continuous erythropoietin receptor activator
  • Erythropoietin
  • Polyethylene Glycols